Victory Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $398K | Buy |
42,426
+30,634
| +260% | +$287K | ﹤0.01% | 2098 |
|
2025
Q1 | $83.8K | Sell |
11,792
-590
| -5% | -$4.2K | ﹤0.01% | 2327 |
|
2024
Q4 | $144K | Sell |
12,382
-272
| -2% | -$3.17K | ﹤0.01% | 2288 |
|
2024
Q3 | $260K | Buy |
12,654
+429
| +4% | +$8.82K | ﹤0.01% | 2162 |
|
2024
Q2 | $274K | Sell |
12,225
-174
| -1% | -$3.89K | ﹤0.01% | 2123 |
|
2024
Q1 | $341K | Buy |
12,399
+567
| +5% | +$15.6K | ﹤0.01% | 2083 |
|
2023
Q4 | $361K | Sell |
11,832
-15,484
| -57% | -$472K | ﹤0.01% | 2080 |
|
2023
Q3 | $864K | Buy |
27,316
+470
| +2% | +$14.9K | ﹤0.01% | 1731 |
|
2023
Q2 | $1.09M | Sell |
26,846
-210
| -0.8% | -$8.56K | ﹤0.01% | 1622 |
|
2023
Q1 | $1.01M | Buy |
27,056
+1,761
| +7% | +$65.6K | ﹤0.01% | 1690 |
|
2022
Q4 | $883K | Sell |
25,295
-533
| -2% | -$18.6K | ﹤0.01% | 1800 |
|
2022
Q3 | $1.45M | Sell |
25,828
-2,437
| -9% | -$136K | ﹤0.01% | 1563 |
|
2022
Q2 | $1.46M | Sell |
28,265
-559,666
| -95% | -$29M | ﹤0.01% | 1578 |
|
2022
Q1 | $42M | Sell |
587,931
-39,566
| -6% | -$2.83M | 0.04% | 594 |
|
2021
Q4 | $74.2M | Sell |
627,497
-141,959
| -18% | -$16.8M | 0.07% | 394 |
|
2021
Q3 | $103M | Buy |
769,456
+375,933
| +96% | +$50.4M | 0.1% | 259 |
|
2021
Q2 | $63.7M | Buy |
393,523
+353,428
| +881% | +$57.2M | 0.06% | 454 |
|
2021
Q1 | $3.22M | Buy |
40,095
+4,503
| +13% | +$361K | ﹤0.01% | 1496 |
|
2020
Q4 | $1.94M | Sell |
35,592
-1,793
| -5% | -$97.5K | ﹤0.01% | 1524 |
|
2020
Q3 | $743K | Buy |
+37,385
| New | +$743K | ﹤0.01% | 1826 |
|
2020
Q2 | – | Sell |
-10,846
| Closed | -$132K | – | 3008 |
|
2020
Q1 | $132K | Buy |
10,846
+2,332
| +27% | +$28.4K | ﹤0.01% | 2449 |
|
2019
Q4 | $125K | Buy |
8,514
+3,493
| +70% | +$51.3K | ﹤0.01% | 2469 |
|
2019
Q3 | $67K | Buy |
+5,021
| New | +$67K | ﹤0.01% | 2569 |
|